Results 81 to 90 of about 13,339 (123)

Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritis. [PDF]

RMD Open
Nevins IS, van der Pol JA, Van Ouwerkerk L, Helmich GS, Bos R, Van Der Kooij SM, Vonkeman HE, Bijsterbosch J, de Jong PHP, Güler-Yüksel M, Böhringer S, Huizinga TWJ, van Gaalen FA, Bergstra SA.   +13 more
europepmc   +1 more source

Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Am J Clin Dermatol
Morriss S, Foo CH, Lin E, Rodrigues Dias F, Kushnir-Grinbaum D, FitzGerald H, Leemaqz S, Lee S, Bhoyrul B.   +8 more
europepmc   +1 more source

Refractory perioral dermatitis treated with baricitinib: A case report and literature review. [PDF]

JAAD Case Rep
Chung KG, Shin MK.
europepmc   +1 more source

Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. [PDF]

Eurasian J Med
Kan Y, Uhara H.
europepmc   +1 more source

Skeletal effects of JAK1/2 inhibition versu<i>s</i> IL-6 receptor blockade in rheumatoid arthritis: a <i>post hoc</i> comparative cohort analysis based on two prospective observational studies. [PDF]

Front Pharmacol
Schulz N, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +5 more
europepmc   +1 more source

Effect of JAK Inhibitors on Pain Management in Patients with Rheumatoid Arthritis: A Literature Review. [PDF]

J Clin Med
Kowalska A, Jawoszek A, Borkowska A, Chmielewski G, Jaśkiewicz Ł, Krajewska-Włodarczyk M.   +5 more
europepmc   +1 more source

JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports. [PDF]

Dermatol Res Pract
Vahabi SM, Heidari S, Farahmand Y, Pourgholi E, Kianfar N, Memari H, Esmaeili F, Bahramian S, Etesami I, Ansari MS.   +9 more
europepmc   +1 more source

Differential regulation of basal and interferon-induced <i>APOL1</i> gene expression in podocytes. [PDF]

Am J Physiol Renal Physiol
Huang C, Wu Z, Bartolomeo KR, O'Toole JF, Sedor JR, Bruggeman LA.   +5 more
europepmc   +1 more source

Clinical and Pharmacogenetic Factors Associated with Response to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Real-World Study of <i>JAK1</i>, <i>JAK2</i>, and <i>JAK3</i> Gene Variants. [PDF]

Pharmaceutics
Roldán AM, Márquez Pete N, Sánchez Suárez MDM, Rojo Tolosa S, Jiménez Morales A.   +4 more
europepmc   +1 more source